The Intellectual Property Management team at Chugai Pharmabody Research is responsible for the strategic oversight and protection of the company's proprietary innovations in antibody drug discovery. This team evaluates, develops, and manages patent portfolios to safeguard intellectual assets, ensuring compliance with IP regulations while facilitating innovation and collaboration within the industry. Ultimately, their work enables CPR to advance its mission of developing effective therapies for patients with unmet medical needs.
View all